Alto Ingredients, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) In Thousands, except Share data	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings / Accumulated Deficit	Noncontrolling Interest	Total
Beginning balance, value at Dec. 31, 2011	$ 1	$ 6	$ 556,952	$ (509,985)	$ 72,290	$ 119,264
Beginning balance, shares at Dec. 31, 2011	927,000	5,775,000
Stock-based compensation expense - restricted stock and options to employees and directors, net of cancellations, value			806			806
Stock-based compensation expense - restricted stock and options to employees and directors, net of cancellations, shares		(3,000)
Shares issued on equity offerings, stock issued		3,700,000
Shares issued on equity offerings, value		4	15,856			15,860
Warrant exercises, shares issued		15,000
Warrant exercises, value			139			139
Shares issued as payment of prior unpaid Series B preferred dividends, shares		302,000
Shares issued as payment of prior unpaid Series B preferred dividends, value			1,462			1,462us-gaap_DividendsCommonStock
Purchases of interests in PE Op Co.			7,646		(27,647)	(20,001)
Preferred stock dividends				(1,268)		(1,268)us-gaap_DividendsPreferredStock
Net income (loss)				(19,057)	(24,298)	(43,355)us-gaap_ProfitLoss
Ending balance, value at Dec. 31, 2012	1	10	582,861	(530,310)	20,345	72,907
Ending balance, shares at Dec. 31, 2012	927,000	9,789,000
Stock-based compensation expense - restricted stock and options to employees and directors, net of cancellations, value		1	1,696			1,697
Stock-based compensation expense - restricted stock and options to employees and directors, net of cancellations, shares		600,000
Shares issued on convertible notes, shares issued		4,446,000
Shares issued on convertible notes, value		4	18,551			18,555
Shares issued on senior notes, shares issued		500,000
Shares issued on senior notes, value			2,000			2,000peix_SharesIssuedOnSeniorNotesValue
Warrant exercises, shares issued		280,000
Warrant exercises, value			2,317			2,317
Shares issued as payment of prior unpaid Series B preferred dividends, shares		511,000
Shares issued as payment of prior unpaid Series B preferred dividends, value		1	2,192			2,193us-gaap_DividendsCommonStock
Purchases of interests in PE Op Co.			11,940		(14,281)	(2,341)
Preferred stock dividends				(1,265)		(1,265)us-gaap_DividendsPreferredStock
Net income (loss)				(781)	(381)	(1,162)us-gaap_ProfitLoss
Ending balance, value at Dec. 31, 2013	1	16	621,557	(532,356)	5,683	94,901
Ending balance, shares at Dec. 31, 2013	927,000	16,126,000
Stock-based compensation expense - restricted stock and options to employees and directors, net of cancellations, value			1,890			1,890
Stock-based compensation expense - restricted stock and options to employees and directors, net of cancellations, shares		90,000
Shares issued on equity offerings, stock issued		1,750,000
Shares issued on equity offerings, value		2	26,071			26,073
Warrant exercises, shares issued		6,413,000
Warrant exercises, value		6	85,156			85,162
Shares issued as payment of prior unpaid Series B preferred dividends, shares		120,000
Shares issued as payment of prior unpaid Series B preferred dividends, value		1	1,462			1,463us-gaap_DividendsCommonStock
Purchases of interests in PE Op Co.			(79)		(5,921)	(6,000)
Tax impact of purchases of interests in PE Op Co.			(10,244)			(10,244)
Preferred stock dividends				(1,265)		(1,265)us-gaap_DividendsPreferredStock
Net income (loss)				21,289	4,713	26,002us-gaap_ProfitLoss
Ending balance, value at Dec. 31, 2014	$ 1	$ 25	$ 725,813	$ (512,332)	$ 4,475	$ 217,982
Ending balance, shares at Dec. 31, 2014	927,000	24,499,000